M&A Deal Summary

Incline Therapeutics Acquires ALZA Corp - IONSYS

On June 21, 2010, Incline Therapeutics acquired medical products company ALZA Corp - IONSYS from ALZA

Acquisition Highlights
  • This is Incline Therapeutics’ 1st transaction in the Medical Products sector.
  • This is Incline Therapeutics’ 1st transaction in the United States.

M&A Deal Summary

Date 2010-06-21
Target ALZA Corp - IONSYS
Sector Medical Products
Buyer(s) Incline Therapeutics
Sellers(s) ALZA
Deal Type Divestiture

Target

ALZA Corp - IONSYS

United States
ALZA Corp - IONSYS™ (fentanyl iontophoretic transdermal system) is an investigational product candidate intended to provide patient-controlled analgesia for adult inpatients requiring opioids following surgery.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Incline Therapeutics

Redwood City, California, United States

Category Company
Founded 2009
Sector Medical Products
DESCRIPTION

Incline Therapeutics, Inc. is a company focused on the development of IONSYS® (fentanyl iontophoretic transdermal system), a compact, disposable, needleless Patient-Controlled Analgesia (PCA) system in development for the short-term management of acute postoperative pain in the hospital setting.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2010 M&A 1 of 1

Seller(S) 1

SELLER

ALZA

Mountain View, California, United States

Category Company
Founded 1968
Sector Life Science
Employees2,442
DESCRIPTION

ALZA Corporation, headquartered in Mountain View, California, is a research-based pharmaceutical company and a leader in drug delivery technologies. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. ALZA's sales and marketing efforts have been focused in oncology and urology.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2010 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1999-03-26 Sequus Pharmaceuticals

Menlo Park, California, United States

Sequus Pharmaceuticals, Inc. manufactures, develops, and distributes pharmaceutical products to treat cancer and infectious diseases.

Buy -